Director at Treace Medical (TMCI) receives 30,000 restricted stock units

Rhea-AI Filing Summary

Jain Deepti reported acquisition or exercise transactions in this Form 4 filing.

Treace Medical Concepts director Deepti Jain reported receiving a grant of 30,000 restricted stock units (RSUs) of common stock at no purchase price. These RSUs will vest 100% on the earlier of May 19, 2027 or the 2027 annual meeting of stockholders, conditioned on continued service. Following this award, Jain holds 100,243 shares in total, including the 30,000 RSUs.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Jain Deepti

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	30,000	$0.00	--

Holdings After Transaction: Common Stock — 100,243 shares (Direct, null)

Footnotes (1)

1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date. Includes 30,000 restricted stock units.

Key Figures

RSU grant size: 30,000 RSUs Transaction price: $0.0000 per share Post-transaction holdings: 100,243 shares +2 more

5 metrics

RSU grant size 30,000 RSUs Restricted stock units granted on May 19, 2026

Transaction price $0.0000 per share Reported price per share for RSU grant

Post-transaction holdings 100,243 shares Total common stock holdings after RSU award

Vesting date Earlier of May 19, 2027 or 2027 annual meeting RSUs vest 100% on earliest of these dates

RSUs included in total 30,000 RSUs Footnote states total holdings include these RSUs

Key Terms

restricted stock units (RSUs), vesting, annual meeting of stockholders

3 terms

restricted stock units (RSUs) financial

"Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share"

Restricted stock units (RSUs) are a type of company promise to give employees shares of stock in the future, usually after certain conditions like working for a set time. They are like a gift promised today that you receive later, which can become valuable if the company's stock price goes up. RSUs matter because they are a way companies reward employees and can be a significant part of compensation.

vesting financial

"receive one (1) share of Issuer's Common Stock for each RSU upon vesting."

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

annual meeting of stockholders financial

"on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders"

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Jain Deepti

(Last) (First) (Middle)

C/O TREACE MEDICAL CONCEPTS, INC.

100 PALMETTO PARK PLACE

(Street)

PONTE VEDRA FLORIDA 32081

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
TREACE MEDICAL CONCEPTS, INC. [ TMCI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/19/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/19/2026		A		30,000(1)	A	$0	100,243(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents restricted stock units (RSUs) for which the Reporting Person is entitled to receive one (1) share of Issuer's Common Stock for each RSU upon vesting. The RSUs will be 100% vested on the earlier of (a) May 19, 2027 or (b) the date of the 2027 annual meeting of stockholders, subject to Reporting Person's providing continued service to Issuer through the vesting date.

2. Includes 30,000 restricted stock units.

	/s/ Lisa Taylor as Attorney-in-fact for Deepti Jain	05/19/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Treace Medical Concepts (TMCI) director Deepti Jain report in this Form 4?

Director Deepti Jain reported receiving a grant of 30,000 restricted stock units (RSUs) of Treace Medical Concepts common stock. The award was reported as an acquisition at no purchase price and increased her total reported holdings to 100,243 shares, including these RSUs.

How many Treace Medical Concepts (TMCI) RSUs were granted to Deepti Jain?

Deepti Jain was granted 30,000 restricted stock units (RSUs) of Treace Medical Concepts common stock. Each RSU entitles her to receive one share of common stock upon vesting, subject to the vesting schedule and continued service requirements described in the filing’s footnotes.

When will Deepti Jain’s 30,000 Treace Medical (TMCI) RSUs vest?

The 30,000 RSUs will be 100% vested on the earlier of May 19, 2027 or the date of Treace Medical Concepts’ 2027 annual meeting of stockholders. Vesting is conditioned on Jain continuing to provide service to the company through the applicable vesting date.

What are Deepti Jain’s total Treace Medical (TMCI) holdings after this RSU grant?

After the reported RSU grant, Deepti Jain’s total holdings are 100,243 shares of Treace Medical Concepts common stock. This total explicitly includes the 30,000 restricted stock units disclosed in the footnotes, which each convert into one share upon vesting, subject to conditions.

Does Deepti Jain pay a purchase price for the Treace Medical (TMCI) RSUs?

The Form 4 shows a transaction price per share of 0.0000 for the 30,000 RSUs, indicating no cash purchase price. Instead, these RSUs are a compensation-related grant that converts into common shares upon vesting, assuming continued service to Treace Medical Concepts.